Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cellegesic for Pain in Chronic Anal Fissure
NCT00522041Phase 3Completed
- Sponsor
- Forest Laboratories
- Start
- Aug 2007
- Primary completion
- Jul 2008
- Modality
- Transdermal Patches, Hydrogel Systems, Small Molecules
01
Overview
A Phase 3 trial of nitroglycerin in chronic anal fissure (CAF), sponsored by Forest Laboratories. Started Aug 2007; status: completed.
02
Drugs
nitroglycerin
03
Conditions
chronic anal fissure (CAF)
Beyond the preview
Go deeper on NCT00522041.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00522041.